Incidence and time course of everolimus-related adverse events in postmenopausal women with hormone receptor-positive advanced breast cancer: insights from BOLERO-2.

Auteurs : Rugo HS, Pritchard KI, Gnant M, Noguchi S, Piccart-Gebhart M, Hortobagyi G, Baselga J, Perez A, Geberth M, Csoszi T, Chouinard E, Srimuninnimit V, Puttawibul P, Eakle J, Feng W, Bauly H, El-Hashimy M, Taran T, Burris HA
Année : 2014
Journal : Ann Oncol
Volume : 25(4)
Pages : 808-15